Apaziquone for non-muscle invasive bladder cancer: a critic

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
Apaziquone for non-muscle invasive bladder cancer: a critic
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


Expert Opinion on Investigational Drugs , July 2008, Vol. 17, No. 7, Pages 1085-1096.
<br/>
Objective: To describe clinical needs in non-muscle invasive bladder cancer (NMIBC) and review the potential of apaziquone in this respect. Methods: Epidemiology and clinical practice in NMIBC, as well as new drugs and strategies are reviewed. Results: ...

Read more...

Source: Expert Opinion: Expert Opinion on Investigational Drugs: Table of Contents
Table of Contents for Expert Opinion on Investigational Drugs. List of articles from both the latest and ahead of print issues.
View user's profileSend private message
Apaziquone for non-muscle invasive bladder cancer: a critic
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map